Electrocardiographic left ventricular hypertrophy Cornell product is a feasible predictor of cardiac prognosis in patients with chronic heart failure

Clinical Research in Cardiology

Volumn 103, Issue 4, 2014, Pages 275-284

  Otaki, Yoichiro ^a   Takahashi, Hiroki ^a   Watanabe, Tetsu ^a   Kadowaki, Shinpei ^a   Narumi, Taro ^a   Honda, Yuki ^a   Hasegawa, Hiromasa ^a   Honda, Shintaro ^a   Funayama, Akira ^a   Nishiyama, Satoshi ^a   Arimoto, Takanori ^a   Shishido, Tetsuro ^a   Miyashita, Takehiko ^a   Miyamoto, Takuya ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Cornell product; Heart failure; Left ventricular geometry; Left ventricular hypertrophy

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORNELL PRODUCT; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GEOMETRY; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; PREDICTIVE VALUE; PREDICTOR VARIABLE; PREVALENCE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84897026793     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0646-2     Document Type: Article

References (35)

1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106(24):3068-3072 (Pubitemid 35440290)
2. McMurray JJ, Petrie MC, Murdoch DR, Davie AP (1998) Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 19(Suppl P):P9-P16
3. Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101(1):1-10. doi:10.1007/s00392-011-0348-6
4. Molloy TJ, Okin PM, Devereux RB, Kligfield P (1992) Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 20(5):1180-1186
5. Okin PM, Roman MJ, Devereux RB, Kligfield P (1996) Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity. J Am Coll Cardiol 27(1):124-131. doi:10.1016/0735-1097(95)00421-1 (Pubitemid 26018926)
6. Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, Coats AJ (1999) Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 70(2):171-178 (Pubitemid 29354368)
7. Kashani A, Barold SS (2005) Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 46(12):2183-2192. doi:10.1016/j.jacc.2005.01.071 (Pubitemid 41785483)
8. Kannel WB (1991) Left ventricular hypertrophy as a risk factor: the Framingham experience. J Hypertens Suppl 9(2):S3-S8 discussion S8-S9
9. Lok DJ, Lok SI, Bruggink-Andre de la Porte PW, Badings E, Lipsic E, van Wijngaarden J, de Boer RA, van Veldhuisen DJ, van der Meer P (2013) Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol 102(2):103-110. doi:10.1007/s00392-012-0500-y
10. De Keulenaer GW, Brutsaert DL (2007) Systolic and diastolic heart failure: different phenotypes of the same disease? Eur J Heart Fail 9(2):136-143. doi:10.1016/j.ejheart.2006.05.014 (Pubitemid 46394077)
11. Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, Kuzuya T, Hirota S, Koyama T, Miwa T, Hori M (2000) Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens 18(1):111-120 (Pubitemid 30093716)
12. Wachtell K, Okin PM, Olsen MH, Dahlof B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K (2007) Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study. Circulation 116(7):700-705. doi:10.1161/circulationaha.106.666594 (Pubitemid 47260463)
13. Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithell HO (2001) Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 103(19):2346-2351 (Pubitemid 32448798)
14. Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlof B (2007) Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients. Ann Intern Med 147(5):311-319 (Pubitemid 351664558)
15. Bender SR, Friedman DJ, Markowitz SM, Lerman BB, Okin PM (2012) Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. J Interv Card Electrophysiol. doi:10.1007/s10840-011-9661-2
16. McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285(26):1441-1446. doi:10.1056/nejm197112232852601
17. Rodrigues SL, Angelo LC, Baldo MP, Dantas EM, Barcelos AM, Pereira AC, Krieger JE, Mill JG (2013) Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study. Clin Res Cardiol 102(9):653-659. doi:10.1007/s00392-013-0578-x
18. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP (1987) Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 59(9):956-960 (Pubitemid 17074242)
19. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E (2004) Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43(4):731-738. doi:10.1161/01.HYP. 0000121223.44837.de (Pubitemid 38405579)
20. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19(7):1550-1558
21. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982-992. doi:10.1053/j.ajkd. 2008.12.034
22. Niizeki T, Takeishi Y, Arimoto T, Takahashi T, Okuyama H, Takabatake N, Nozaki N, Hirono O, Tsunoda Y, Shishido T, Takahashi H, Koyama Y, Fukao A, Kubota I (2005) Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure. Circ J 69(8):922-927 (Pubitemid 41124259)
23. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143(1):29-36 (Pubitemid 12142173)
24. Okin PM, Roman MJ, Devereux RB, Kligfield P (1995) Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 25(2):417-423
25. Norman JE Jr, Levy D (1996) Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity. J Electrocardiol 29(Suppl):241-247 (Pubitemid 27051663)
26. Aktoz M, Erdogan O, Altun A (2007) Electrocardiographic prediction of left ventricular geometric patterns in patients with essential hypertension. Int J Cardiol 120(3):344-350. doi:10.1016/j.ijcard.2006.10.010 (Pubitemid 47069560)
27. Okin PM (2009) Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients. J Electrocardiol 42(6):584-588. doi:10.1016/j.jelectrocard.2009.06.020
28. Barrabes JA, Figueras J, Cortadellas J, Lidon RM, Ibars S (2009) Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction. Am J Cardiol 103(4):455-460. doi:10.1016/j.amjcard. 2008.10.006
29. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK (1996) The progression from hypertension to congestive heart failure. JAMA 275(20):1557-1562 (Pubitemid 26154241)
30. Sandhu R, Bahler RC (2004) Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol 93(2):244-246 (Pubitemid 38058744)
31. Rautaharju PM, Zhou SH, Calhoun HP (1994) Ethnic differences in ECG amplitudes in North American white, black, and Hispanic men and women. Effect of obesity and age. J Electrocardiol 27(Suppl):20-31 (Pubitemid 124034256)
32. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L (2006) Euro Heart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27(22):2725-2736. doi:10.1093/eurheartj/ehl193 (Pubitemid 44729876)
33. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88(1):107-115 (Pubitemid 23195439)
34. Shiba N, Shimokawa H (2008) Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag 4(1):103-113 (Pubitemid 351460851)
35. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H (2011) Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: first report from the CHART-2 study. Circ J 75(4):823-833